SLC7A5 and breast carcinoma: In conclusion, miR-126 decreases proliferation and mammosphere formation of MCF-7, ER+ BC cell line, which suggests that this miR might play a tumor suppressor role in ER+ breast cancer through potentially targeting SLC7A5 (LAT1), a sodium-independent transporter overexpressed in cancer.